fbpx

Media

Leader Biomedical | Blueman

Leader Biomedical Group commences operations in India

Leader Biomedical Group has increased its global footprint by establishing an entity in Bangalore, India: Leader Biomedical and Surgicals India Pvt. Ltd (“Leader Biomedical India”).…

cleaner-grafts-safer-outcomes

Leader Biomedical launches DBM, cleaned with supercritical carbon dioxide (eCOO® Clean)

Leader Biomedical Group is pleased to announce the launch of its own line of demineralised Bone Matrix (DBM), cleaned using our proprietary supercritical carbon dioxide…

Blueman_BW_Background

Leader Biomedical acquires a stake in Osteo-Pharma

Leader Biomedical acquired a stake in Osteo-Pharma, a promising research-focused start-up based in Oss, the Netherlands. With this investment, Leader Biomedical is now the company’s…

leaderbiomedical-favicon

New corporate strategy bears first fruit

HONG KONG and AMSTERDAM – Leader Biomedical, the parent company of EMCM and affiliate of aap Joints, continues to deliver on its corporate strategy through…

2

EMCM optimises ampoule and vial filling

EMCM, a Leader Biomedical Group company, made a strategic investment to increase its capacity to fill ampoules and vials with the purchase of a fully…

EMCM-manufacturing-contract manufacturing

EMCM starts manufacturing nutraceutical liquid for UK customer

EMCM, a Leader Biomedical Group company, proudly announced that it started producing a nutraceutical product for a pharmaceutical company based in the UK. EMCM established…

EBJIS recognises allograft study

The European Bone and Joint Infection Society (EBJIS) recognised an allograft study conducted by Dr. D. Link from EMCM, Leader Biomedical Group company, at their…

shutterstock_3326208

GMP certified Reniale® production possible

The Dutch Healthcare Inspectorate (IGZ) and Farmatec/CIBG granted EMCM, a Leader Biomedical Group company, GMP certification. Along with the GMP certification, EMCM also received the…

EMCM partners with CritiTech to develop coated tissue grafts

EMCM, a Leader Biomedical Group company, partnered with CritiTech, a rapidly growing drug development company, to develop tissue grafts coated with a variety of pharmaceuticals…